Acticor Biotech Aktie

NeuKaufen Kaufen Verkaufen Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

0,2080 EUR -8,2320 EUR -97,54 %

10.12.2024

STU

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.3,94 Mio. EUR

Div. Rendite0,00%

WKNA3C6GM

ISINFR0014005OJ5

Acticor Biotech Aktien News

Sortieren:Datum Meistgelesen

15.03.24BusinesswireActicor Biotech Completes a Capital Increase for a Total Gross Amount of 8 Million Euros

14.03.24BusinesswireActicor Biotech Launches a Capital Increase of a Minimum of 7 Million Euros

14.09.23BusinesswireACTICOR Adapts Its ACTISAVE Clinical Study to Prepare the Registration of Glenzocimab for the Treatment of Stroke

WerbungActicor Biotech-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

07.09.23BusinesswireThe UK Regulatory Agency (MHRA) Approved the Protocol of LIBERATE Study, the First Clinical Trial Evaluating Glenzocimab for Heart Attacks

31.08.23BusinesswireACTIMIS Post-hoc Results on Imaging Stroke Data Using Artificial Intelligence Reinforces Glenzocimab Mode of Action in Stroke Patients

30.05.23BusinesswireActicor Biotech: Progress in Discussions with EU and US Regulatory Agencies

09.03.23BusinesswireActicor Biotech Successfully Completes a Capital Increase for a Total Gross Amount of 12.2 Million Euros, via the Issuance of 1,793,005 Shares

08.03.23BusinesswireActicor Biotech Launches a Capital Increase for an Amount of C. 10 Million Euros

09.01.23BusinesswireUpdate on Acticor Biotech's clinical developments with glenzocimab in the treatment of cardiovascular emergencies

05.12.22BusinesswireActicor Biotech Receives European Medicines Agency (EMA) Endorsement on Key Parameters of ACTISAVE, Its Pivotal Phase II/III Study for Registration in Stroke

22.11.22BusinesswireActicor Biotech: World’s First Clinical Trial to Test New Drug Glenzocimab for Heart Attacks

18.10.22BusinesswireActicor Biotech Strengthens Its Financial Structure

26.09.22BusinesswireActicor Biotech Announces the Enrollment of the First US Patient in its Phase 2/3 Study ACTISAVE for the Treatment of Stroke

09.05.22BusinesswireACTICOR BIOTECH: Presentation of Positive Results From the ACTIMIS Phase 1b/2a Study in Stroke at ESOC 2022

30.03.22BusinesswireActicor Biotech Announces Its 2021 Full-year Financial Results and Gives an Update on Its Clinical Development

Acticor Biotech News

Acticor Biotech News: auf dieser Seite finden Sie alle Acticor Biotech News und Nachrichten zur Acticor Biotech Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Acticor Biotech News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Acticor Biotech News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.